Concordia Healthcare Corp. to Host Fiscal 2013 Year-End Results Conference Call

TORONTO, March 24, 2014 /CNW/ - Concordia Healthcare Corp. ("Concordia") (TSX: CXR) (OTCQX: CHEHF) today announced it will release its 2013 year-end financial results on Monday, March 31, 2014, before market open. The Company will subsequently hold a conference call on Monday, March 31, 2014, at 8:30 a.m. ET hosted by Mr. Mark Thompson, President and Chief Executive Officer, and Mr. Leith Tessy, Chief Financial Officer. A question-and-answer session will follow the corporate update.

CONFERENCE CALL DETAILS
 
DATE:   Monday, March 31, 2014
     
TIME:   8:30 a.m. ET
     
DIAL-IN NUMBER:   (647) 427-7450 or (888) 231-8191
     
TAPED REPLAY:   (416) 849-0833 or (855) 859-2056
     
REFERENCE NUMBER:   15804692

This call is being webcast and can be accessed from the Concordia website at www.concordiarx.com. An archived replay of the webcast will be available for one year.

About Concordia

Concordia is a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs and medical devices for the diabetic population. The company's legacy pharmaceutical business consists of an ADHD-treatment drug, Kapvay® (clonidine extended release tablets), Ulesfia® (benzyl alcohol) Lotion a Head Lice Treatment, and an Asthma-related medication, Orapred ODT® (prednisolone sodium phosphate orally disintegrating tablets). Concordia's Specialty Healthcare Distribution (SHD) division (Complete Medical Homecare) distributes medical supplies targeting diabetes and related conditions. Concordia's orphan division, Pinnacle, markets Photofrin® in the United States.

Concordia operates out of facilities in Oakville, Ontario, Lenexa, Kansas (near Kansas City, Missouri), Bannockburn, (near Chicago), Illinois and Bridgetown, Barbados

SOURCE Concordia Healthcare Corp.

For further information:

For more information, please visit www.concordiarx.com or contact:

Kristen Van Vogt
TMX Equicom
416-815-0700 x 244
kvanvogt@tmxequicom.com

Adam Peeler
TMX Equicom
416-815-0700 x 225
apeeler@tmxequicom.com